Cell and Gene Therapy CRO Market 2030, By Type of Therapy (Cell Therapy, Gene Therapy), Scale of Operation (Drug Discovery, Preclinical and Clinical), Therapeutic Area and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

Industry : Healthcare | Pages : 196 Pages | Published On : Mar 2024


The Cell and Gene Therapy CRO Market was valued USD 600 Million in 2023 and projected to reach USD 1,368.4 Million by 2030, growing at a CAGR of 12.5% during the forecast period of 2023-2030.

Cell and Gene Therapy CRO Market Size

             2019                         2023-2030      

Market Size ValueUSD 600 Million in 2023
Market Size ValueUSD 1,368.4 Million by 2030
Forecast Period2023-2030
Historic Data2019
Forecast UnitsValue (USD Million/USD Billion)
Segments CoveredType of Therapy, Therapeutic Area and Region
Geographics CoveredNorth America, Europe, Asia Pacific, and RoW

Major vendors in the global Cell and Gene Therapy CRO Market: Altasciences, Allucent, Accelera Charles River Laboratories, Creative Biolabs, CMIC, Evotec, ICON, IQVIA, Labcorp, Medpace, PPD, Precision For Medicine, QPS and Syneos Health and Others.

Market Overview

The Cell and Gene Therapy (CRO) market refers to the specialized sector within the broader field of biopharmaceuticals that provides contract research services specifically tailored to the unique needs of developers and manufacturers of cell and gene therapies. The Cell and Gene Therapy (CRO) Market is experiencing notable growth within the broader biopharmaceutical sector. As a specialized segment, it caters to the dynamic needs of cell and gene therapy developers by offering comprehensive research services. The market is characterized by increasing investments, collaborations, and a surge in clinical trials for innovative therapies. CROs play a pivotal role in accelerating the development of cell and gene therapies, providing expertise in regulatory compliance, clinical trial design, and manufacturing processes. This market's trajectory is driven by the rising prominence of advanced therapies in treating various diseases, showcasing its pivotal role in shaping the future of healthcare.

Rise in healthcare expenditure

The escalating global healthcare expenditure stands as a driver propelling the Cell and Gene Therapy (CRO) market into a phase of unprecedented growth. As countries worldwide increase their investments in healthcare infrastructure, research, and development, the demand for advanced therapeutic solutions, including cell and gene therapies, experiences a simultaneous surge. The intricate nature of these therapies necessitates specialized expertise, driving biopharmaceutical companies to seek the support of CROs. The rise in healthcare expenditure facilitates these collaborations, enabling CROs to provide essential services in clinical trial management, regulatory compliance, and research optimization. This financial commitment to healthcare underscores a commitment to innovation, positioning the Cell and Gene Therapy CRO market as a vital player in advancing the frontiers of medical science and translating groundbreaking research into transformative therapies for patients globally.

Market Dynamics


  • Rise in healthcare expenditure
  • Global Adoption of Advanced Therapies


  • Increasing spending in R&D activities
  • Technological Innovations in Manufacturing

Increasing spending in R&D activities

The increasing allocation of funds towards research and development (R&D) activities presents a significant opportunity for the Cell and Gene Therapy Contract Research Organization (CRO) market. As the cell and gene therapy landscape evolves, driven by advancements and breakthroughs, the need for specialized R&D support becomes imperative. The financial commitment to R&D reflects a proactive approach in addressing complex challenges associated with developing innovative therapies. CROs, positioned at the forefront of this transformative field, stand to benefit from heightened investments. The opportunity lies in offering tailored services that streamline R&D processes, enhance clinical trial efficiency, and navigate intricate regulatory landscapes. As biopharmaceutical companies intensify their efforts to bring novel cell and gene therapies to market, the collaboration with CROs equipped with cutting-edge R&D capabilities becomes a strategic imperative, fostering innovation and accelerating the development of groundbreaking treatments.

The market for Cell and Gene Therapy CRO is dominated by North America.

North America asserts its dominance as the epicenter of the Cell and Gene Therapy Contract Research Organization (CRO) market, showcasing a formidable influence in shaping the industry landscape. The region's preeminence is underscored by a convergence of factors, including advanced healthcare infrastructure, substantial investments in biopharmaceutical research, and a thriving ecosystem of innovative biotechnology companies. The United States, in particular, stands as a focal point for cutting-edge developments in cell and gene therapies, fostering a dynamic environment for collaborations between biopharmaceutical firms and specialized CROs. The regulatory framework's adaptability and support further contribute to North America's leadership in facilitating seamless research and development activities. With a concentration of key industry players, research institutions, and a robust clinical trial landscape, North America continues to lead the Cell and Gene Therapy CRO Market, solidifying its position as a global hub for advancing transformative therapies in the field of biopharmaceuticals.

The Drug Discovery Segment is Anticipated to Hold the Largest Market Share During the Forecast Period

Based on Scale of Operation the Cell and Gene Therapy CRO market is segmented into Drug Discovery, Preclinical and Clinical. The Drug Discovery segment emerges as the dominant force in the Cell and Gene Therapy Contract Research Organization (CRO) market, and its influence is anticipated to extend into the future. As the demand for innovative therapies intensifies, the emphasis on Drug Discovery CRO services becomes pivotal in accelerating the development of cell and gene therapies. This segment encompasses a spectrum of crucial activities, including target identification, lead optimization, and preclinical testing, all of which are integral to bringing transformative therapies to market. The anticipated dominance in the future underscores the continued reliance on CROs to navigate the complexities of drug discovery in the evolving landscape of cell and gene therapies. This trajectory reflects the pivotal role Drug Discovery CROs play in advancing research, optimizing development pipelines, and contributing to the realization of groundbreaking treatments for various diseases.

Segmentations Analysis of Cell and Gene Therapy CRO Market: -

  • By Type of Therapy:
    • Cell Therapy
    • Gene Therapy
  • By Scale of Operation:
    • Drug Discovery
    • Preclinical and Clinical
  • By Therapeutic Area:
    • Oncological Disorders
    • Neurological Disorders
    • Cardiovascular Disorders
    • Infectious Diseases
    • Metabolic Disorders
    • Autoimmune Disorders
    • Blood Disorders
    • Rare / Genetic Disorders
    • Ophthalmological Disorders
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
      • Chile
      • Peru
      • Rest of Latin America
    • Europe
      • Germany
      • France
      • Italy
      • Spain
      • U.K.
      • BENELUX
      • CIS & Russia
      • Nordics
      • Austria
      • Poland
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Thailand
      • Indonesia
      • Malaysia
      • Vietnam
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Nigeria
      • Egypt
      • Israel
      • Turkey
      • Rest of MEA

 Recent Developments

  • In April 2022, Microsoft announced the expansion of its confidential VM family with the launch of the DCesv5-series and ECesv5-series in preview. Featuring 4th Gen Intel Xeon Scalable processors, these VMs are backed by an all-new hardware-based Trusted Execution Environment called Intel Trust Domain Extensions (TDX). Organizations can use these VMs to seamlessly bring confidential workloads to the cloud without any code changes to their applications.
  • In April 2023, Google and Intel collaborated on a new research project to identify potential security vulnerabilities in Intel's new Cell and Gene Therapy CRO technology, Intel Trust Domain Extensions (Intel TDX). In addition to an expanded feature set, Intel Tdx offers full vm compute models without requiring any code changes.  

Answers to Following Key Questions:

  • What will be the Cell and Gene Therapy CRO Market’s Trends & growth rate? What analysis has been done of the prices, sales, and volume of the top producers in the Cell and Gene Therapy CRO Market?
  • What are the main forces behind worldwide Cell and Gene Therapy CRO Market? Which companies dominate Cell and Gene Therapy CRO Market?
  • Which companies dominate Cell and Gene Therapy CRO Market? Which business possibilities, dangers, and tactics did they embrace in the market?
  • What are the global Cell and Gene Therapy CRO industry's suppliers' opportunities and dangers in Cell and Gene Therapy CRO Market?
  • What is the Cell and Gene Therapy CRO industry's regional sales, income, and pricing analysis? In the Cell and Gene Therapy CRO Market, who are the distributors, traders, and resellers?
  • What are the main geographic areas for various trades that are anticipated to have astounding expansion over the Cell and Gene Therapy CRO Market?
  • What are the main geographical areas for various industries that are anticipated to observe astounding expansion for Cell and Gene Therapy CRO Market?
  • What are the dominant revenue-generating regions for Cell and Gene Therapy CRO Market, as well as regional growth trends?
  • By the end of the forecast period, what will the market size and growth rate be?
  • What are the main Cell and Gene Therapy CRO Market trends that are influencing the market's expansion?
  • Which key product categories dominate Cell and Gene Therapy CRO Market? What is Cell and Gene Therapy CRO Market’s main applications?
  • In the coming years, which Cell and Gene Therapy CRO Market technology will dominate the market?

Reason to purchase this Cell and Gene Therapy CRO Market Report:

  • Determine prospective investment areas based on a detailed trend analysis of the global Cell and Gene Therapy CRO Market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different Cell and Gene Therapy CRO Market segments in the top spending countries across the world and identify the opportunities each offers.
  • Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels that are driving the global Cell and Gene Therapy CRO Market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global Cell and Gene Therapy CRO Market.
  • Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top Cell and Gene Therapy CRO Market providers worldwide, including information about their products, alliances, recent contract wins, and financial analysis wherever available.


Table and Figures


At MarketDigits, we take immense pride in our 360° Research Methodology, which serves as the cornerstone of our research process. It represents a rigorous and comprehensive approach that goes beyond traditional methods to provide a holistic understanding of industry dynamics.

This methodology is built upon the integration of all seven research methodologies developed by MarketDigits, a renowned global research and consulting firm. By leveraging the collective strength of these methodologies, we are able to deliver a 360° view of the challenges, trends, and issues impacting your industry.

The first step of our 360° Research Methodology™ involves conducting extensive primary research, which involves gathering first-hand information through interviews, surveys, and interactions with industry experts, key stakeholders, and market participants. This approach enables us to gather valuable insights and perspectives directly from the source.

Secondary research is another crucial component of our methodology. It involves a deep dive into various data sources, including industry reports, market databases, scholarly articles, and regulatory documents. This helps us gather a wide range of information, validate findings, and provide a comprehensive understanding of the industry landscape.

Furthermore, our methodology incorporates technology-based research techniques, such as data mining, text analytics, and predictive modelling, to uncover hidden patterns, correlations, and trends within the data. This data-driven approach enhances the accuracy and reliability of our analysis, enabling us to make informed and actionable recommendations.

In addition, our analysts bring their industry expertise and domain knowledge to bear on the research process. Their deep understanding of market dynamics, emerging trends, and future prospects allows for insightful interpretation of the data and identification of strategic opportunities.

To ensure the highest level of quality and reliability, our research process undergoes rigorous validation and verification. This includes cross-referencing and triangulation of data from multiple sources, as well as peer reviews and expert consultations.

The result of our 360° Research Methodology is a comprehensive and robust research report that empowers you to make well-informed business decisions. It provides a panoramic view of the industry landscape, helping you navigate challenges, seize opportunities, and stay ahead of the competition.

In summary, our 360° Research Methodology is designed to provide you with a deep understanding of your industry by integrating various research techniques, industry expertise, and data-driven analysis. It ensures that every business decision you make is based on a well-triangulated and comprehensive research experience.

Cell and Gene Therapy CRO Market
Customize your Report
• Tailored advice to Drive your Performance
• Product Planning Strategy
• New Product Stratergy
• Expanded Research Scope
• Comprehensive Research
• Strategic Consulting
• Provocative and pragmatic
• Accelerate Revenue & Growth
• Evaluate the competitive landscape
• Optimize your partner network
• Analyzing industries
• Mapping trends
• Strategizing growth
• Implementing plans
A comprehensive cogent custom study with Analyzing Industries, Mapping Trends, Straterging growth & Implementing Plans. An in-depth and breadth of composite research, which gives complete support of the generation and evaluation of growth opportunities, and best practices recognition to help increase the revenue. Request a Custom Research below.
Request Customization

Covered Key Topics

Growth Opportunities

Market Growth Drivers

Leading Market Players

Company Market Share

Market Size and Growth Rate

Market Trend and Technological

Research Assistance

We will be happy to help you find what you need. Please call us or write to us:

+1 510-730-3200 (USA Number)

Email: sales@marketdigits.com